QF
QVT Financial Portfolio holdings
AUM
$716M
This Quarter Return
+10.8%
1 Year Return
+15.53%
3 Year Return
+157.62%
5 Year Return
+333.57%
10 Year Return
+571.64%
AUM
$1.33B
AUM Growth
+$1.33B
(-5.6%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-16.12%
Top 10 Holdings %
Top 10 Hldgs %
45.69%
Holding
77
New
9
Increased
4
Reduced
19
Closed
5
Top Buys
| 1 |
PHH
PHH Corporation
PHH
|
$21.8M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$11.1M |
| 3 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$7.96M |
| 4 |
ONIT
Onity Group Inc.
ONIT
|
$7.81M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$6.79M |
Top Sells
| 1 |
ETFC
E*Trade Financial Corporation
ETFC
|
$45.3M |
| 2 |
DST
DST Systems Inc.
DST
|
$28M |
| 3 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$24.4M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
$24.3M |
| 5 |
Tesla
TSLA
|
$24.2M |
Sector Composition
| 1 | Healthcare | 27.56% |
| 2 | Financials | 15.13% |
| 3 | Energy | 8.27% |
| 4 | Consumer Staples | 1.83% |
| 5 | Materials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tenet Healthcare
THC
$16.3B
| $71.7M | 4.88% | 1,739,793 +75,300 | +5% | +$3.1M |
|
|
VVUS
2
DELISTED
Vivus Inc
VVUS
| $68.1M | 4.64% | 7,327,748 -1,018,949 | -12% | -$9.48M |
|
3
Halozyme
HALO
$8.56B
| $49.9M | 3.4% | 4,519,800 -81,700 | -2% | -$902K |
|
|
PCYC
4
DELISTED
PHARMACYCLICS INC
PCYC
| $47.6M | 3.24% | 344,321 -175,661 | -34% | -$24.3M |
|
5
Capital One
COF
$145B
| $43.2M | 2.94% | 628,835 -149,400 | -19% | -$10.3M |
|
|
ITMN
6
DELISTED
INTERMUNE INC
ITMN
| $39.1M | 2.66% | 2,543,468 -318,400 | -11% | -$4.9M |
|
7
Green Dot
GDOT
$771M
| $36.8M | 2.51% | 1,397,642 -96,539 | -6% | -$2.54M |
|
|
RDC
8
DELISTED
Rowan Companies Plc
RDC
| $35.8M | 2.44% | 975,954 | – | – |
|
|
ACHN
9
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $35.4M | 2.41% | 11,712,953 +745,100 | +7% | +$2.25M |
|
10
YPF
YPF
$12B
| $34.4M | 2.34% | 1,706,509 | – | – |
|
11
Scorpio Tankers
STNG
$2.57B
| $32M | 2.18% | 3,278,084 -500,000 | -13% | -$4.88M |
|
12
JPMorgan Chase
JPM
$829B
| $30.9M | 2.1% | 597,660 -23,800 | -4% | -$1.23M |
|
|
LM
13
DELISTED
Legg Mason, Inc.
LM
| $28.2M | 1.92% | 842,168 | – | – |
|
14
BRF SA
BRFS
$6.12B
| $24.5M | 1.67% | 997,220 | – | – |
|
|
INFI
15
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $23.1M | 1.57% | 1,326,610 | – | – |
|
16
Citigroup
C
$178B
| $22.3M | 1.52% | 459,873 | – | – |
|
|
PHH
17
DELISTED
PHH Corporation
PHH
| $21.8M | 1.49% | +919,355 | New | +$21.8M |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $21M | 1.43% | 344,960 -272,718 | -44% | -$16.6M |
|
19
CBRE Group
CBRE
$48.2B
| $19.2M | 1.31% | 831,320 | – | – |
|
|
MDVN
20
DELISTED
MEDIVATION, INC.
MDVN
| $18.3M | 1.25% | 305,128 -242,500 | -44% | -$14.5M |
|
|
ARRY
21
DELISTED
Array Biopharma Inc
ARRY
| $17.9M | 1.22% | 2,878,600 -558,693 | -16% | -$3.48M |
|
|
ETFC
22
DELISTED
E*Trade Financial Corporation
ETFC
| $16.8M | 1.14% | 1,016,518 -2,746,975 | -73% | -$45.3M |
|
|
DYAX
23
DELISTED
DYAX CORPORATION
DYAX
| $16.4M | 1.12% | 2,390,900 +1,620,217 | +210% | +$11.1M |
|
|
ANAC
24
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $14.4M | 0.98% | 1,358,303 | – | – |
|
25
Wells Fargo
WFC
$263B
| $14.2M | 0.97% | 344,292 -75,000 | -18% | -$3.1M |
|